KAIST·파스퇴르연구소 "오미팔리십, 렘데시비르보다 항바이러스 활성 200배"

https://www.sciencetimes.co.kr/news/%ea%b8%b0%ec%a1%b4-%ec%95%bd%eb%ac%bc-%ea%b0%80%ec%83%81-%ec%8a%a4%ed%81%ac%eb%a6%ac%eb%8b%9d%ed%95%b4-%ec%bd%94%eb%a1%9c%eb%82%9819-%ec%b9%98%eb%a3%8c-%ed%9b%84%eb%b3%b4%eb%ac%bc%ec%a7%88-%ec%b0%be/?cat=130